Assicurazioni Generali SpA:企業のM&A・事業提携・投資動向

◆英語タイトル:Assicurazioni Generali SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1434
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Assicurazioni Generali SpA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Assicurazioni Generali SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Assicurazioni Generali SpA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Assicurazioni Generali SpA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Assicurazioni Generali SpA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Assicurazioni Generali SpA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Assicurazioni Generali SpA and its subsidiaries since 2007.
- Information about key financial and legal advisors for Assicurazioni Generali SpA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Assicurazioni Generali SpA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 94
Corporate Venturing – Deal reports 94
PARTNERSHIP 100
Partnership – Deal reports 100
CAPITAL RAISING 115
Capital Raising – Overview 115
Capital Raising – Deal reports 116
DIVESTMENTS 121
Divestments – Overview 121
Divestments – Deal reports 122
PRIVATE EQUITY & OWNERSHIP 166
Private Equity and Ownership – Overview 166
Private Equity and Ownership – Deal reports 167
APPENDIX 190
Contact Us 190
About MarketLine Financial Deals Database 190
Deal Definition and Methodology 192
About MarketLine 199

List of Tables
Table 1: Assicurazioni Generali S.p.A. M&A volume and value trend (2014-YTD2018)
Table 2: Assicurazioni Generali S.p.A. M&A activity by geography (2014-YTD2018)
Table 3: Assicurazioni Generali S.p.A. capital raising volume and value trend (2014-YTD2018)
Table 4: Assicurazioni Generali S.p.A. capital raising by deal type (2014-YTD2018)
Table 5: Assicurazioni Generali S.p.A. divestments volume and value trend (2014-YTD2018)
Table 6: Assicurazioni Generali S.p.A. divestments activity by geography (2014-YTD2018)
Table 7: Assicurazioni Generali S.p.A. private equity and ownership volume and value trend (2014-YTD2018)
Table 8: Assicurazioni Generali S.p.A. private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Assicurazioni Generali S.p.A. M&A volume and value trend (2014-YTD2018)
Figure 2: Assicurazioni Generali S.p.A. M&A activity by geography (2014-YTD2018)
Figure 3: Assicurazioni Generali S.p.A. capital raising volume and value trend (2014-YTD2018)
Figure 4: Assicurazioni Generali S.p.A. capital raising by deal type (2014-YTD2018)
Figure 5: Assicurazioni Generali S.p.A. divestments volume and value trend (2014-YTD2018)
Figure 6: Assicurazioni Generali S.p.A. divestments by geography (2014-YTD2018)
Figure 7: Assicurazioni Generali S.p.A. private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: Assicurazioni Generali S.p.A. private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Assicurazioni Generali SpA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Voyager Therapeutics Inc (VYGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • ScanSource Inc (SCSC):企業の財務・戦略的SWOT分析
    ScanSource Inc (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Societe Generale S.A.:企業の戦略・SWOT・財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Shalimar Paints Ltd (SHALPAINTS):企業の財務・戦略的SWOT分析
    Shalimar Paints Ltd (SHALPAINTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Firmenich SA:企業の戦略的SWOT分析
    Firmenich SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Zuivelcooperatie FrieslandCampina UA:企業の戦略的SWOT分析
    Zuivelcooperatie FrieslandCampina UA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • The Dai-ichi Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Dai-ichi Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Brooks MacDonald Group PLC (BRK)
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務情報
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Devon Energy Corporation (DVN)-石油・ガス分野:企業M&A・提携分析
    Summary Devon Energy Corporation (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its operations in onshore areas of the US and Canada. Devon Energy’s US assets are located in …
  • Barco N.V.:企業の戦略・SWOT・財務情報
    Barco N.V. - Strategy, SWOT and Corporate Finance Report Summary Barco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • OncoTherapy Science Inc (4564)-医療機器分野:企業M&A・提携分析
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs. The company offers products under clinical development and anti-cancer medicines. It provides technology platforms that include laser micro-beam microdissection, cDNA microarray and i …
  • Mitsubishi Electric Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Electric Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Electric Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Publix Super Markets, Inc.:企業の戦略・SWOT・財務分析
    Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zimmer Biomet Holdings Inc (ZBH):医療機器:M&Aディール及び事業提携情報
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and tho …
  • Galilee Energy Ltd (GLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offers exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP79 …
  • AvStar Aviation Services Inc:企業の戦略的SWOT分析
    AvStar Aviation Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is develope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆